Description

Molecular Otology is a new field of Otolaryngology that encompasses an understanding of the molecular physiology of the inner ear and the development of precision therapies for patients. With gene therapy trials for hearing loss underway, there is a need for a specialized course to educate surgeons in the theory and application of Molecular Otology.

This unique course leverages the expertise of the Boston Children’s team, which has expertise in gene therapy clinical trials. We aim to provide practical experience to surgeons, helping them better evaluate and treat patients who may be candidates for these innovative therapies

Course Directors:
Eliot Shearer, MD PhD (Boston Children’s Hospital/Harvard Medical School, USA)
Aaron Remenschneider, MD MPH (Boston Children’s Hospital/Harvard Medical School, USA)
Hubert Löwenheim, MD PhD (University of Tübingen, Germany)

Course Format 

This course will be held in person at 201 Brookline Ave Boston, MA 02215. 

Learning Objectives: 

At the conclusion of this educational program, learners will be able to:

1. To understand required clinical diagnostic evaluation for children undergoing consideration for gene therapy for hearing loss.
2. To describe the most commonly used viral vectors and promoters used for inner ear gene therapy.
3. To gain practical, hands on expertise to surgical approaches to gene therapy of the inner ear.

To register, please click on the register tab above. If this is your first time registering for a conference at Boston Children’s Hospital, you will need to create an account. Returning users can log in to their account to complete the registration process.   

Registration Type	Early Bird Rate*	Regular Rate	Live Surgical Session**
Physician	$600.00	$800.00	Additional price TBD
Student/Trainee	$350.00	$400.00	Additional price TBD

*Early bird rate ends April 3, 2026.

**If you wish to add an additional live surgical session with hands-on dissection, please select this registration option. The additional price will be determined and communicated to you before any charges are applied.

Pre-registration is required. Once you have registered you will receive a confirmation email with a registration receipt. Course access instructions will be sent a few days prior to the course launch. If you have questions or need assistance with registration, please direct all inquiries to cmedepartment@childrens.harvard.edu.

Online Course Cancellation, Transfer & Refund Policy
Due to the propriety materials and content of each course, online virtual courses orders are NOT eligible for refund, cancellation or transfer.

Other Terms and Conditions:
Online training courses may NOT be transferred to another Participant. Participants have 2 weeks to access any virtual online course content. Participants have until the expiration date to access and complete any enduring material courses. Boston Children’s Hospital CE is not responsible for user technical difficulties including loss of internet, power outages, etc. 

Cancellation of Services
Although highly unlikely, in case an event is canceled or postponed, Boson Children’s can provide a full refund or offer a credit towards future events to those who have already registered.

Refund Policy
Refunds will be made in the following ways: For payments received by credit or debit cards, the same credit/debit card will be refunded.

Accreditation

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

 

Physician

Boston Children’s Hospital designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity. 

Disclosure Policy 
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:

Mitigation of Relevant Financial Relationships

Boston Children’s Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.